Free Republic

Bioethics: British and Japanese researchers have been awarded this year's Nobel Prize for showing how to create embryonic stem cells without using human embryos in a genuinely promising line of research. For decades now, embryonic stem cell research (ESCR) has been trumpeted as the most promising avenue of research, and those who had moral qualms about using human embryos were dismissed as Bible-thumping troglodytes who stood in the way of making the lame walk. ESCR supporters said their way led to finding "imminent" miracle cures to tragic and sometimes deadly conditions and diseases. They dismissed suggestions of a more promising...

Bioethics: British and Japanese researchers have been awarded this year's Nobel Prize for showing how to create embryonic stem cells without using human embryos in a genuinely promising line of research. For decades now, embryonic stem cell research (ESCR) has been trumpeted as the most promising avenue of research, and those who had moral qualms about using human embryos were dismissed as Bible-thumping troglodytes who stood in the way of making the lame walk. ESCR supporters said their way led to finding "imminent" miracle cures to tragic and sometimes deadly conditions and diseases. They dismissed suggestions of a more promising...

Bioethics: The former director of the National Institutes of Health, once an enthusiast for embryonic stem cells, now says their future has "dimmed." So why is the administration bailing out research into such therapies while troubled states like California have committed billions?Aside from creating or saving a few research jobs, the administration's decision to federally fund embryonic stem cell research is, as we've noted, a bailout of bad science. It throws money at an avenue of research that time and adult stem cell progress have passed by. Applauding the administration's move was Sen. Arlen Specter, D-Pa., who echoed the claims...

Subsidies: A firm that received tax dollars to pursue embryonic stem cell research abandons what was touted as the most promising avenue of research for medical miracles. Then there's that "conscience thing." When Geron Corp. announced in January 2010 that the first clinical trial using its embryonic stem cells to treat an actual human patient was under way, its stock shot up 6.4%. Geron got the first Food and Drug Administration license to use embryonic stem cells to treat people in a clinical trial, in this case patients with a spinal cord injury. Last week Geron announced that it was...

Science: Supporters of California's failed 2004 stem-cell law will ask strapped taxpayers to support another $3 billion bond initiative in 2014. Maybe it's time to restore fiscal sanity as well as science to its rightful place. When it was passed in 2004, Proposition 71, with its $3 billion state fund and 10-year mandate for embryonic stem-cell research (ESCR), held out the promise of imminent miracle cures for everything from spinal disorders to Parkinson's. One campaign ad showed actor Christopher Reeve, aka Superman, asking California voters to "stand up for those who can't." Some six years later, with about $1.1 billion...

Bioethics: A federal judge rules that the administration violated congressional intent when it lifted restrictions on federal funding for embryonic stem cell research. No, this will not usher in a new dark age. The ruling by U.S. District Judge Royce Lamberth was striking enough. Lamberth said that when President Obama lifted Bush administration restrictions on ESCR, he violated the Dickey-Wicker Amendment. First passed in 1996, and passed every year as part of the federal budget, Dickey-Wicker blocks federal funds for stem cell research in which human embryos are destroyed. Perhaps more striking is the press coverage of Lamberth's ruling. The...

Bioethics: Five years after a budget-busting $3 billion was allocated to embryonic stem cell research, there have been no cures, no therapies and little progress. So supporters are embracing research they once opposed. California's Proposition 71 was intended to create a $3 billion West Coast counterpart to the National Institutes of Health, empowered to go where the NIH could not — either because of federal policy or funding restraints on biomedical research centered on human embryonic stem cells. Supporters of the California Stem Cell Research and Cures Initiative, passed in 2004, held out hopes of imminent medical miracles that were...